Weight Loss11 min read·Published July 2, 2026·Updated October 19, 2026

Best Weight Loss Pills: Prescription and OTC Options

A practical comparison of prescription pills, GLP-1 medications, OTC orlistat, safety, eligibility, and online care.

Best Weight Loss Pills: A Patient's Guide to Prescription and OTC Options

The best weight loss pills are usually prescription medications, not supplements. Phentermine-topiramate and bupropion-naltrexone are established oral options, while orlistat is the only FDA-approved over-the-counter pill. GLP-1 medicines can lead to greater average weight loss in trials, but the most studied options for obesity are injections rather than pills. The right choice depends on your health history, side effects, cost, and clinician review 12.

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

How did we evaluate the best weight loss pills?

We ranked options by the quality of human trial evidence, average results, safety limits, FDA-approved use, and practical access. Clinical evidence over about one year or longer matters more than bold supplement marketing. A medicine that works well for one person may be unsafe or unsuitable for another because of pregnancy, heart disease, high blood pressure, mental-health history, current medicines, or cost 1.

What counts as a weight loss pill?

A “weight loss pill” can mean a prescription drug, an FDA-approved OTC drug, or a dietary supplement. These are three very different categories. Prescription drugs go through clinical testing and require clinician oversight. Supplements do not receive FDA premarket review for safety or effectiveness in the same way drugs do 17.

Prescription oral medications

Prescription pills include phentermine-topiramate (Qsymia), bupropion-naltrexone (Contrave), phentermine (Adipex-P), and prescription-strength orlistat (Xenical). They are used alongside nutrition, activity, and behavior changes—not as a replacement for them 1.

Over-the-counter options

Alli is the only FDA-approved OTC weight loss pill. It contains orlistat 60 mg, which reduces absorption of some dietary fat. It is not an OTC injection, and there are currently no FDA-approved OTC GLP-1 injections 6.

Supplements versus drugs

Products marketed as fat burners, metabolism boosters, appetite suppressants, or GLP-1 supplements are dietary supplements, not FDA-approved weight-loss drugs. Some contain fiber or caffeine-based ingredients, but product quality and evidence vary widely. FDA warns that some weight-loss supplements have contained hidden drug ingredients 7.

Which weight loss pill is most effective?

Among established FDA-approved oral medicines, phentermine-topiramate has produced the largest average weight loss in pivotal trials. GLP-1 medicines may produce more average weight loss overall, but the strongest obesity trial evidence is for injectable semaglutide and tirzepatide rather than an FDA-approved “Wegovy pill” 489.

1. Phentermine-topiramate (Qsymia): best established oral option for average results

  • Best for: adults who qualify for a prescription oral medicine and do not have contraindications to either ingredient.
  • In the CONQUER trial, participants receiving the higher studied dose had about 9.8% average weight loss at 56 weeks, alongside lifestyle changes 4.
  • Risks include tingling, dry mouth, taste changes, insomnia, mood effects, and increased heart rate. It can cause fetal harm and is contraindicated in pregnancy; it also has important restrictions for glaucoma, hyperthyroidism, and recent MAO-inhibitor use 4.

2. Bupropion-naltrexone (Contrave): best when appetite and food-reward patterns are part of the discussion

  • Best for: selected adults who can safely use both bupropion and naltrexone.
  • In the COR-I trial, average weight loss was greater with bupropion-naltrexone than placebo when both groups received lifestyle advice 5.
  • Common effects include nausea, constipation, headache, dizziness, and trouble sleeping. The label includes a boxed warning about suicidal thoughts and behaviors associated with antidepressants, and it is not appropriate for people with seizure disorders, uncontrolled hypertension, chronic opioid use, or certain eating disorders 5.

3. Orlistat (Xenical): best non-stimulant prescription pill

  • Best for: people who prefer a medicine that works in the digestive tract rather than on appetite signals in the brain.
  • Orlistat blocks intestinal lipases, reducing absorption of some fat from food. In the XENDOS trial, it supported more weight loss than placebo when paired with lifestyle changes 10.
  • Oily stools, gas, leakage, and urgent bowel movements are common, especially after higher-fat meals. Orlistat can reduce absorption of fat-soluble vitamins and is not appropriate for chronic malabsorption or cholestasis 6.

4. Phentermine (Adipex-P): best known short-term appetite suppressant

  • Best for: limited, clinician-supervised use when a stimulant is medically appropriate.
  • Phentermine is FDA-approved only for short-term use as an adjunct to lifestyle changes, not as a long-term chronic weight-management medicine 1.
  • It may raise heart rate and blood pressure and can cause jitteriness, dry mouth, or insomnia. It is not appropriate for many people with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, or recent MAO-inhibitor use 1.

5. Alli (orlistat 60 mg): best FDA-approved OTC pill

  • Best for: adults looking for an OTC drug with a defined active ingredient and label instructions.
  • Alli is the lower-strength OTC version of orlistat. Average results are generally smaller than with prescription medicines, but it has FDA-reviewed labeling and can be useful for some people 6.
  • Digestive side effects are common, and it can interact with some medicines. A pharmacist or clinician can help review whether it fits with your medical history 6.

How do prescription weight loss pills compare?

The best option is not always the one with the largest average result. Safety, route, cost, and your medical history matter as much as efficacy. The figures below are trial averages, not promises of individual results 1.

OptionHow it worksEvidence-based average resultKey limitations
Phentermine-topiramateAppetite and satiety pathwaysAbout 8% to 10% in a 56-week pivotal trial 4Pregnancy risk; stimulant and mood-related effects 4
Bupropion-naltrexoneAppetite and reward pathwaysAbout 5% to 9% across trials 5Not for seizure disorders, chronic opioid use, or uncontrolled hypertension 5
Orlistat prescriptionReduces fat absorptionModest average loss with lifestyle treatment 10GI effects and vitamin-absorption concerns 6
Alli OTCLower-strength orlistatModest average loss with a reduced-fat diet 6GI effects; not an OTC GLP-1 6
Semaglutide injectionGLP-1 receptor agonist14.9% average loss at 68 weeks in STEP 1 8GI effects and GLP-1 contraindications 2
Tirzepatide injectionDual GIP/GLP-1 receptor agonistUp to 20.9% average loss at 72 weeks in SURMOUNT-1 9GI effects and GLP-1-class warnings 3

Are GLP-1 pills as effective as injections?

Not usually, based on the strongest published obesity trials. Weekly injectable semaglutide and tirzepatide have the clearest large-trial evidence for double-digit average weight loss. Oral GLP-1 research is evolving, but a pill should not be assumed to match an injection simply because the medicines are in the same class 89.

Wegovy is the brand name for injectable semaglutide approved for chronic weight management; Ozempic is injectable semaglutide approved for type 2 diabetes. Likewise, Zepbound is tirzepatide approved for chronic weight management, while Mounjaro is approved for type 2 diabetes 23. Searches for “Wegovy pill” may refer to oral semaglutide research or other oral GLP-1 medicines, but a clinician or pharmacist should verify the exact product, approved use, and formulation.

Common GLP-1 side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Their labels also include important warnings, including pancreatitis and gallbladder problems, and contraindications for people with a personal or family history of medullary thyroid carcinoma or MEN 2 23.

3-min quiz

Explore clinician-guided weight management

At Chia, a licensed US provider can review your history online and discuss whether compounded semaglutide or compounded tirzepatide may be clinically appropriate. Tirzepatide is available as tablets from $249/month or injections from $299/month; semaglutide injections start at $249/month. A prescription requires a medical evaluation and is not guaranteed. Compounded medications are prepared by state-licensed US 503A pharmacies, shipped to your door, and are not FDA-approved.

Who qualifies for prescription weight loss pills?

For many FDA-approved chronic weight-management medicines, eligibility is based on BMI 30 or higher, or BMI 27 or higher with a weight-related condition. Conditions may include high blood pressure, type 2 diabetes, abnormal cholesterol, or sleep apnea 1.

A clinician also reviews pregnancy plans, blood pressure, kidney and liver history, mental-health history, current medicines, and prior medication reactions. Liraglutide (Saxenda) is a daily GLP-1 injection for chronic weight management, while setmelanotide (Imcivree) is reserved for specific rare genetic causes of obesity—not routine weight management 1.

What are the side effects and risks of weight loss pills?

Side effects depend on the medicine. The safest choice is the one that fits your health history, not the one with the best headline result. Your clinician should review risks before prescribing and reassess tolerability over time 1.

  • GLP-1 medicines: nausea, vomiting, diarrhea, constipation, abdominal pain, and possible dehydration; serious warnings include pancreatitis and gallbladder disease 23.
  • Phentermine-topiramate: tingling, dry mouth, insomnia, altered taste, mood changes, and fetal harm risk 4.
  • Bupropion-naltrexone: nausea, headache, constipation, dizziness, insomnia, blood-pressure concerns, and mental-health warnings 5.
  • Orlistat: oily stools, gas, fecal urgency, and reduced absorption of fat-soluble vitamins 6.

What about OTC weight loss pills and supplements?

If you want an OTC medicine, Alli is the evidence-based option to recognize. It is not risk-free, but it has an FDA-reviewed drug label. Most other shelf products are supplements and should not be presented as equivalent to prescription medication or OTC orlistat 67.

Fiber supplements may help some people feel fuller, but they are not weight-loss drugs. Green tea extract and stimulant-heavy fat burners have limited evidence for meaningful sustained weight loss and can cause side effects or interact with medicines. For a closer look at what is and is not supported, see our guide to over-the-counter weight loss medications 7.

How can you get weight management care through Chia?

At Chia, care begins with an online health questionnaire and licensed-provider review. Our providers evaluate whether medication is clinically appropriate, review contraindications and current medicines, and guide dosing over time. A prescription is never guaranteed.

For patients who are prescribed a Chia GLP-1 option, we offer compounded semaglutide by injection and compounded tirzepatide as tablets or injection. Microdosing plans are available when clinically appropriate. Medications are compounded by state-licensed US 503A pharmacies and shipped to the patient’s door; patients can message their care team through the portal between visits. Our tirzepatide online guide and weight-loss medication cost guide can help you compare questions to ask before choosing a care path.

Chia optionAvailable formCurrent starting priceWhat to know
Compounded semaglutideInjectionFrom $249/monthProvider-guided care; microdosing plans may be available
Compounded tirzepatideTablet or injectionTablets from $249/month; injections from $299/monthProvider-guided care; microdosing plans may be available

Plans and eligibility can change, so see the semaglutide treatment page or tirzepatide treatment page for current details. These compounded medications are not FDA-approved, and results are not established for compounded formulations through FDA-reviewed outcomes data.

Frequently asked questions

3-min quiz

Start with a clinical evaluation

If you are considering prescription weight-management treatment, a Chia provider can review your health history online and discuss options that may fit your goals. A prescription requires a medical evaluation and is not guaranteed. Chia’s compounded medications are prepared by state-licensed US 503A pharmacies and are not FDA-approved.

References

  1. 1.National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight & Obesity. National Institutes of Health, 2023.
  2. 2.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. Novo Nordisk, 2025.
  3. 3.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. Eli Lilly and Company, 2025.
  4. 4.U.S. Food and Drug Administration. Qsymia (phentermine and topiramate extended-release) prescribing information. Vivus LLC, 2025.
  5. 5.U.S. Food and Drug Administration. Contrave (naltrexone hydrochloride and bupropion hydrochloride) prescribing information. Currax Pharmaceuticals LLC, 2024.
  6. 6.GlaxoSmithKline Consumer Healthcare. alli (orlistat) Drug Facts and product information. 2024.
  7. 7.U.S. Food and Drug Administration. Weight Loss Product Notifications. U.S. Food and Drug Administration, 2024.
  8. 8.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 2021.
  9. 9.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022.
  10. 10.Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study. Diabetes Care, 2004.
  11. 11.Garvey WT, Ryan DH, Look M, et al. Two-Year Sustained Weight Loss and Metabolic Benefits with Controlled-Release Phentermine/Topiramate in Obese and Overweight Adults. American Journal of Clinical Nutrition, 2012.
  12. 12.Greenway FL, Fujioka K, Plodkowski RA, et al. Effect of Naltrexone Plus Bupropion on Weight Loss in Overweight and Obese Adults. Lancet, 2010.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides